Sao Paulo Clínicas Liver Cancer Group, Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clínicas, Department of Gastroenterology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil
Sao Paulo Clínicas Liver Cancer Group, Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clínicas, Department of Gastroenterology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil
Sao Paulo Clínicas Liver Cancer Group, Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clínicas, Department of Gastroenterology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil
Sao Paulo Clínicas Liver Cancer Group, Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clínicas, Department of Gastroenterology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil
Sao Paulo Clínicas Liver Cancer Group, Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clínicas, Department of Gastroenterology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil
Medical Oncology, Instituto do Cancer do Estado de Sao Paulo (ICESP), Sao Paulo, Brazil
Medical Oncology, Instituto do Cancer do Estado de Sao Paulo (ICESP), Sao Paulo, Brazil
Sao Paulo Clínicas Liver Cancer Group, Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clínicas, Department of Gastroenterology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil
Copyright © 2016 Regiane S. S. M. Alencar, Luciana Kikuchi, Cláudia M. Tani, Aline L. Chagas, Cinira C. Camargo, Túlio E. F. Pfiffer, Paulo M. G. Hoff, Flair J. Carrilho et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Alencar, R. , Kikuchi, L. , Tani, C. , Chagas, A. , Camargo, C. , Pfiffer, T. , Hoff, P. and Carrilho, F. (2016) Better Management of Adverse Events Favors Sorafenib Treatment of HCC Patients and Impact on Survival.
Journal of Cancer Therapy,
7, 275-284. doi:
10.4236/jct.2016.74029.